The composition of the Nomination Committee has now been established, and IRRAS today announced that the Nomination Committee for the annual general meeting 2023 consists of the following persons:
Christer Hellström , chairman of the nomination committee, representingBacara Holdings Limited Philippe Audi , representingSpetses Investments Limited Yana Vlasova , representingLexington Holding Assets Limited Marios Fotiadis , Chairman of the Board ofIRRAS AB
The Nomination Committee's proposals will be presented in the Notice to the annual general meeting 2023 and on IRRAS' website, www.irras.com.
Shareholders who wish to submit proposals to the Nomination Committee can do so by sending an e-mail to nomination@irras.com (subject "Nomination Committee") or by letter posted to
About IRRAS
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in
IRRAS maintains its headquarters in
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
Director, Investor Relations
sten.gustafsson@irras.com
+46 102 11 5172
The information was released for public disclosure, through the agency of the contact person above, on
https://news.cision.com/irras/r/nomination-committee-for-the-irras-2023-annual-general-meeting,c3677889
(c) 2022 Cision. All rights reserved., source